Cargando…

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome

INTRODUCTION: Adults with Down syndrome (DS) are predisposed to Alzheimer’s disease (AD) and reveal early amyloid beta (Aβ) pathology in the brain. Positron emission tomography (PET) provides an in vivo measure of Aβ throughout the AD continuum. Due to the high prevalence of AD in DS, there is need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zammit, Matthew D., Tudorascu, Dana L., Laymon, Charles M., Hartley, Sigan L., Zaman, Shahid H., Ances, Beau M., Johnson, Sterling C., Stone, Charles K., Mathis, Chester A., Klunk, William E., Cohen, Ann D., Handen, Benjamin L., Christian, Bradley T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953340/ https://www.ncbi.nlm.nih.gov/pubmed/33421595 http://dx.doi.org/10.1016/j.neuroimage.2021.117728

Ejemplares similares

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

White matter microstructure associations to amyloid burden in adults with Down syndrome
por: Bazydlo, Austin M., et al.
Publicado: (2021)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
por: Lao, Patrick J., et al.
Publicado: (2017)

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
por: Lao, Patrick J., et al.
Publicado: (2018)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application
por: Minhas, Davneet S., et al.
Publicado: (2020)

Physical activity, memory function, and hippocampal volume in adults with Down syndrome
por: Peven, Jamie C., et al.
Publicado: (2022)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [(11)C]PiB amyloid imaging
por: Laymon, Charles M., et al.
Publicado: (2021)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down’s syndrome
por: Brown, Stephanie S.G., et al.
Publicado: (2022)

Sleep and White Matter in Adults with Down Syndrome
por: Fleming, Victoria, et al.
Publicado: (2021)

Relationship of amyloid-β1–42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study
por: Lopez, Oscar L, et al.
Publicado: (2019)

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults
por: Snitz, Beth E., et al.
Publicado: (2020)

Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
por: Price, Julie C, et al.
Publicado: (2012)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
por: Verberk, Inge M. W., et al.
Publicado: (2018)

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load
por: Minhas, Davneet S., et al.
Publicado: (2018)

Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease
por: Ikonomovic, Milos D., et al.
Publicado: (2020)

The pattern of amyloid accumulation in the brains of adults with Down syndrome
por: Annus, Tiina, et al.
Publicado: (2016)

Association Between Earliest Amyloid Uptake and Functional Connectivity in Cognitively Unimpaired Elderly
por: Hahn, Andreas, et al.
Publicado: (2019)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation
por: Skouras, Stavros, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
por: Cole, James H., et al.
Publicado: (2017)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
por: Ikonomovic, Milos D., et al.
Publicado: (2008)

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
por: Ikonomovic, Milos D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9nuh64d7h8rns3u3omq0cs9p8b